Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

The9 (NCTY) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for The9 (NCTY) over the last 17 years, with Q2 2025 value amounting to $5.0 million.

  • The9's Cash & Equivalents rose 15354.7% to $5.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.0 million, marking a year-over-year increase of 15354.7%. This contributed to the annual value of $1.5 million for FY2024, which is 7381.92% down from last year.
  • As of Q2 2025, The9's Cash & Equivalents stood at $5.0 million, which was up 15354.7% from $1.5 million recorded in Q4 2024.
  • The9's Cash & Equivalents' 5-year high stood at $130.0 million during Q2 2021, with a 5-year trough of $1.5 million in Q4 2024.
  • Over the past 5 years, The9's median Cash & Equivalents value was $3.0 million (recorded in 2023), while the average stood at $18.2 million.
  • Per our database at Business Quant, The9's Cash & Equivalents crashed by 9139.76% in 2022 and then skyrocketed by 15354.7% in 2025.
  • Over the past 5 years, The9's Cash & Equivalents (Quarter) stood at $1.9 million in 2021, then skyrocketed by 37.32% to $2.6 million in 2022, then soared by 138.83% to $6.3 million in 2023, then crashed by 75.82% to $1.5 million in 2024, then surged by 228.52% to $5.0 million in 2025.
  • Its Cash & Equivalents stands at $5.0 million for Q2 2025, versus $1.5 million for Q4 2024 and $2.0 million for Q2 2024.